Raymond James Upgrades AmerisourceBergen (ABC) to Strong Buy
More News related to ABC
- NAI500 announces July additions to the 500 list
- AmerisourceBergen Announces Date and Time for Fiscal Third Quarter Earnings Release
- Lazard Capital Initiates Coverage on AmerisourceBergen (ABC) with a Buy
- BioInformatics, LLC New Report - Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations
- J. Lawrence Wilson Retires from AmerisourceBergen Board of Directors
Raymond James upgrades AmerisourceBergen (NYSE: ABC) from Outperform to Strong Buy.
AmerisourceBergen Corporation, a pharmaceutical services company, offers drug distribution and related services to healthcare providers and pharmaceutical manufacturers in the United States, the United Kingdom, and Canada.
Related Categories
UpgradesStocks Mentioned
+8.01Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
